[Remote] Senior Director, National Field Access, Endocrinology at Corcept Therapeutics

Remote

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Proven success leading a national or large regional team of FRMs, Access Specialists, or equivalent roles
Deep knowledge of payer policy, reimbursement processes, HUB services, specialty pharmacy distribution, and patient support programs
Exceptional leadership and people management skills with a track record of building, developing, and retaining high-performing teams

Responsibilities

Lead, mentor, and manage the national FRM team, providing strategic direction, coaching, performance feedback, and professional development
Define and drive national field access strategy for Korlym and Relacorilant, aligning with overall Market Access and Commercial goals
Establish and monitor KPIs, productivity metrics, and business objectives to ensure consistent performance and impact across regions
Oversee field deployment, territory alignments, and resource allocation for optimal coverage and efficiency
Design, implement, and oversee the FRM team’s MBO (Management by Objectives) plan and incentive compensation structure, ensuring alignment with corporate goals, compliance standards, and individual performance metrics
Serve as the primary liaison between the FRM team and internal stakeholders including Sales, HUB, Patient Services, Trade, Market Access, Legal, and Compliance
Partner with Sales Leadership to align field access strategies with account planning and pull-through efforts
Collaborate with Marketing to ensure field teams are aligned on messaging, access tools, and reimbursement support materials
Interface with HUB leadership and SP partners to ensure seamless patient support and issue resolution processes
Provide strategic insights and feedback to Payer and Trade teams regarding payer policy trends, access barriers, and reimbursement landscape dynamics
Lead regular team meetings, field rides, and best practice sharing forums to maintain alignment, foster collaboration, and drive continuous improvement
Review and analyze field intelligence, access data, and patient support trends to identify barriers and proactively develop strategies to address them
Develop and manage budgets, travel, and team operations in compliance with company policies
Partner with Compliance and Legal to ensure all field access activities meet appropriate guidelines and regulations

Skills

Corcept Therapeutics

Develops cortisol modulators for medical conditions

About Corcept Therapeutics

Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing various health issues. Their main product, Korlym, is used to treat Cushing's syndrome, a condition caused by too much cortisol. Korlym was approved by the FDA in 2012 and is the first medication specifically for this disorder. Corcept stands out from competitors by having a strong emphasis on research and development, having discovered over 1,000 unique cortisol modulators. The company aims to expand its range of treatments while also providing educational resources to healthcare professionals and patients to improve understanding and care for cortisol-related conditions.

Menlo Park, CaliforniaHeadquarters

1998Year Founded

$39.7MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Remote Work Options

Flexible Work Hours

Risks

Teva's antitrust lawsuit could lead to legal expenses and market share loss.

Heavy reliance on Korlym makes Corcept vulnerable to market fluctuations.

Recent investments may pressure Corcept for short-term financial performance, impacting R&D.

Differentiation

Corcept specializes in cortisol modulation, a niche with few direct competitors.

Korlym is the first FDA-approved treatment for Cushing's syndrome, a significant market advantage.

Corcept's extensive R&D has led to the discovery of over 1,000 selective cortisol modulators.

Upsides

Increased interest in cortisol therapies for mental health boosts Corcept's R&D prospects.

Advancements in drug delivery systems could enhance Corcept's product efficacy.

The FDA's fast-track designation supports Corcept's innovative cortisol-related treatments.

Land your dream remote job 3x faster with AI

Try Jobo Free